Gastrointestinal system

North and East Devon Health Care Community Shared Care Guidelines – Gastrointestinal system

The following guidelines are currently under review. In the interim, the guidelines remain valid; if GPs have any specific concerns or questions, they should seek advice from the specialist with whom they have agreed to share care.

Click on the links below to access individual guidelines. 

Please see DMARDs (disease-modifying anti-rheumatic drugs) for overview of monitoring requirements for treatment of rheumatological conditions and inflammatory bowel disease:
DMARDs – overview of monitoring requirements for treatment of rheumatological conditions and inflammatory bowel disease (April 2012) Azathioprine and Mercaptopurine for the treatment of inflammatory bowel disease (April 2011) Azathioprine and Mercaptopurine for the treatment of inflammatory bowel disease – KEY CHANGES to updated guideline (April 2012) Ciclosporin - inflammatory bowel disease (January 2007) Methotrexate for the treatment of inflammatory bowel disease (April 2011) Methotrexate for the treatment of inflammatory bowel disease – KEY CHANGES to updated guideline (April 2012) Sulfasalazine for the treatment of inflammatory bowel disease (April 2011) Sulfasalazine for the treatment of inflammatory bowel disease – KEY CHANGES to updated guideline (April 2012)

Rate this page